Consistent with our findings, it has been reported that LINC01094 plays its pro-tumor role in the development of ccRCC by regulating the miR-224-5p/CHSY1 axis (Jiang et al., 2020). This evidence concerns the gene CHSY1 and nonpapillary renal cell carcinoma.